uck2 inhibitor (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
93
Structured Review
MedChemExpress
uck2 inhibitor
Uck2 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uck2+inhibitor/UCK2+Inhibitor-1/pmc12423300-63-0-3
Average 93 stars, based on 1 article reviews
Uck2 Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/uck2+inhibitor/UCK2+Inhibitor-1/pmc12423300-63-0-3
Average 93 stars, based on 1 article reviews
uck2 inhibitor - by Bioz Stars,
2026-09
93/100 stars
Images
1) Product Images from "De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma"
Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma
Journal: EMBO Molecular Medicine
doi: 10.1038/s44321-025-00278-4
Figure Legend Snippet: ( A ) Cell viability of H2452 NF2 wild-type (sgCtrl) and NF2 knockout (sg NF2 -1, sg NF2 -2) cells treated with various doses of the IMPDH inhibitor for 96 h. Representative data from three independent experiments are shown. The data are presented as the mean ± SD. Two-way ANOVA with multiple comparisons was used for statistical analysis. ( B ) Cell viability of H2452 NF2 wild-type (sgCtrl) and NF2 knockout (sg NF2 -1, sg NF2 -2) cells cultured with the indicated concentrations of glucose. The data are presented as the mean ± SD ( n = 3). Two-way ANOVA with multiple comparisons was used for statistical analysis. ( C–E ) Cell viability of H2452 NF2 wild-type (sgCtrl) and NF2 knockout (sg NF2 -1, sg NF2 -2) cells treated with the indicated doses of the UCK2 inhibitor for 96 h at 10 mM ( C ), 5 mM ( D ) and 2.5 mM ( E ) glucose. Representative data from three independent experiments are shown. The data are presented as the mean ± SD. Two-way ANOVA with multiple comparisons was used for statistical analysis. ( F–H ) Cell viability of H2452 NF2 wild-type (sgCtrl) and NF2 knockout (sg NF2 -1, sg NF2 -2) cells treated with the indicated doses of the DHODH inhibitor for 96 h at 10 mM ( F ), 5 mM ( G ) and 2.5 mM ( H ) glucose. Representative data from three independent experiments were shown. The data are presented as the mean ± SD. Two-way ANOVA with multiple comparisons was used for statistical analysis. ( I ) The differences in LFQ intensities from 480 label-free proteomes of the indicated markers between the H2452 sg NF2 -1 and sgCtrl groups. The data are presented as the mean ± SD ( n = 3). A two-tailed unpaired t test was used for statistical analysis. ( J , K ) The mRNA expression of UPP1 ( J ) and cell viability ( K ) of the indicated cell populations transfected with small interfering RNA (siRNA) targeting the negative control or UPP1 for 72 h. The data are presented as the mean ± SD ( n = 3). Two-way ANOVA with multiple comparisons was used for statistical analysis.
Techniques Used: Knock-Out, Cell Culture, Two Tailed Test, Expressing, Transfection, Small Interfering RNA, Negative Control
Related Articles
Knock-Out:Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: Chemicals, enzymes, and other reagents , , .Chemicals, enzymes, and other reagents , , .. UCK2 inhibitor , Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: (Catalog #S2029), cisplatin (Catalog #S1166) and IMPDH inhibitor (mycophenolic; Catalog #S2487) were purchased from Selleck chem (Houston, TX, USA). .. A Cell Culture:Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: Chemicals, enzymes, and other reagents , , .Chemicals, enzymes, and other reagents , , .. UCK2 inhibitor , Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: (Catalog #S2029), cisplatin (Catalog #S1166) and IMPDH inhibitor (mycophenolic; Catalog #S2487) were purchased from Selleck chem (Houston, TX, USA). .. A Two Tailed Test:Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: Chemicals, enzymes, and other reagents , , .Chemicals, enzymes, and other reagents , , .. UCK2 inhibitor , Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: (Catalog #S2029), cisplatin (Catalog #S1166) and IMPDH inhibitor (mycophenolic; Catalog #S2487) were purchased from Selleck chem (Houston, TX, USA). .. A Expressing:Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: Chemicals, enzymes, and other reagents , , .Chemicals, enzymes, and other reagents , , .. UCK2 inhibitor , Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: (Catalog #S2029), cisplatin (Catalog #S1166) and IMPDH inhibitor (mycophenolic; Catalog #S2487) were purchased from Selleck chem (Houston, TX, USA). .. A Transfection:Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: Chemicals, enzymes, and other reagents , , .Chemicals, enzymes, and other reagents , , .. UCK2 inhibitor , Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: (Catalog #S2029), cisplatin (Catalog #S1166) and IMPDH inhibitor (mycophenolic; Catalog #S2487) were purchased from Selleck chem (Houston, TX, USA). .. A Small Interfering RNA:Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: Chemicals, enzymes, and other reagents , , .Chemicals, enzymes, and other reagents , , .. UCK2 inhibitor , Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: (Catalog #S2029), cisplatin (Catalog #S1166) and IMPDH inhibitor (mycophenolic; Catalog #S2487) were purchased from Selleck chem (Houston, TX, USA). .. A Negative Control:Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: Chemicals, enzymes, and other reagents , , .Chemicals, enzymes, and other reagents , , .. UCK2 inhibitor , Article Title: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2 -deficient mesothelioma Article Snippet: (Catalog #S2029), cisplatin (Catalog #S1166) and IMPDH inhibitor (mycophenolic; Catalog #S2487) were purchased from Selleck chem (Houston, TX, USA). .. A |